4.5 Article

High-Throughput Screen of Microbial Metabolites Identifies F1FO ATP Synthase Inhibitors as New Leads for Naegleria fowleri Infection

Related references

Note: Only part of the references are listed.
Article Parasitology

Real-Time PCR Confirmation of a Fatal Case of Primary Amoebic Meningoencephalitis in Turkey Caused by Naegleria fowleri or Brain-Eating Amoeba

Koray Oncel et al.

Summary: This study aimed to raise awareness in the differential diagnosis of meningitis by showing that N. fowleri may also be the causative agent in cases of meningitis in Turkey. The case of an 18-year-old patient with headache symptoms was examined using direct microscopic examination and real-time PCR, confirming N. fowleri as the etiological agent.

ACTA PARASITOLOGICA (2022)

Article Chemistry, Medicinal

Deoxyvasicinone with Anti-Melanogenic Activity from Marine-Derived Streptomyces sp. CNQ-617

Se-eun Lee et al.

Summary: This study found that the marine microbial natural product deoxyvascinone has an anti-melanogenic effect by inhibiting the mRNA expression of melanogenic enzymes, reducing melanin content.

MARINE DRUGS (2022)

Article Chemistry, Multidisciplinary

Identification of Leucinostatins from Ophiocordyceps sp. as Antiparasitic Agents against Trypanosoma cruzi

Jean A. Bernatchez et al.

Summary: The study identified five leucinostatins (A, B, F, NPDG C, and NPDG D) as potent inhibitors of the intracellular amastigote form of T. cruzi, and leucinostatin B also demonstrated in vivo suppression of T. cruzi in a mouse model of Chagas disease. These findings suggest a potential cross-trypanocidal compound class and provide a platform for further chemical derivatization for the development of effective treatments against T. cruzi.

ACS OMEGA (2022)

Article Medicine, Research & Experimental

Cyclolauranes as plausible chemical scaffold against Naegleria fowleri

Inigo Arberas-Jimenez et al.

Summary: Primary amoebic meningoencephalitis (PAM) is a CNS disease caused by Naegleria fowleri, which mainly affects children and young adults with high fatality rate. The marine environment is a valuable source of anti-Naegleria compounds. This study focuses on Laurencia cyclolaurane-type sesquiterpenes as potential chemical models for PAM treatment.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Microbiology

Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba

Brian Shing et al.

Summary: The free-living Acanthamoeba can exist as a trophozoite or cyst and both stages can cause painful blinding keratitis. Infection recurrence occurs in approximately 10% of cases due to the lack of efficient drugs that can kill both trophozoites and cysts. Therefore, the discovery of therapeutics that are effective against both stages is a critical unmet need to avert blindness. Current efforts to identify new anti-Acanthamoeba compounds rely primarily upon assays that target the trophozoite stage of the parasite. We adapted and trained a machine learning, object detection neural network to recognize Acanthamoeba trophozoites and cysts in microscopy images. Our machine learning-based cysticidal assay improved throughput, demonstrated high specificity, and had an exquisite ability to identify noncysticidal compounds. We combined this cysticidal assay with our bioluminescence-based trophocidal assay to screen about 9,000 structurally unique marine microbial metabolites against A. castellanii. Our screen identified a marine metabolite that was both trophocidal and cysticidal.

MICROBIOLOGY SPECTRUM (2022)

Review Immunology

Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri: A Global Review

Radhika Gharpure et al.

Summary: PAM is a rare but deadly disease with a global occurrence. Improved clinician awareness may lead to earlier diagnosis and treatment, potentially increasing survival among PAM patients. The case definition of probable used in this study seems to effectively capture cases of PAM, as shown by similarities in outcomes, clinical course, and CSF profile to confirmed cases. Clinicians could use this case definition in the absence of confirmatory testing to identify cases of PAM.

CLINICAL INFECTIOUS DISEASES (2021)

Review Pharmacology & Pharmacy

New perspectives in oral peptide delivery

Alessandra T. Zizzari et al.

Summary: Peptides, due to their structural diversity, are considered a unique source of innovative active ingredients, but face challenges in development due to their disadvantageous pharmacokinetic properties. Recent efforts have focused on improving the oral bioavailability of peptide drugs, with the latest findings expected to influence future approaches in developing more efficient and safer orally delivered peptides by pharmaceutical companies.

DRUG DISCOVERY TODAY (2021)

Review Oncology

Defueling the cancer: ATP synthase as an emerging target in cancer therapy

Ting Wang et al.

Summary: Reprogramming of cellular metabolism is a hallmark of cancer, with high expression of ATP synthase playing a role. ATP synthase is involved in angiogenesis, tumorigenesis, and metastasis of cancer.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Article Biochemistry & Molecular Biology

Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro

Jose Ignacio Escrig et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Editorial Material Biotechnology & Applied Microbiology

Marine microbial natural products: the evolution of a new field of science

William (Bill) Fenical

JOURNAL OF ANTIBIOTICS (2020)

Article Multidisciplinary Sciences

Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases

Inigo Arberas-Jimenez et al.

SCIENTIFIC REPORTS (2020)

Review Chemistry, Medicinal

Natural products and other inhibitors of F1FO ATP synthase

Bhargav A. Patel et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Immunology

Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni

Alexandra Probst et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Review Chemistry, Medicinal

Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets

Renato B. Pereira et al.

MARINE DRUGS (2019)

Article Parasitology

The therapeutic strategies against Naegleria fowleri

Natalia Karla Bellini et al.

EXPERIMENTAL PARASITOLOGY (2018)

Article Biotechnology & Applied Microbiology

Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A

Lyudmila N. Lysenkova et al.

JOURNAL OF ANTIBIOTICS (2017)

Article Tropical Medicine

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)

Anjan Debnath et al.

PLoS Neglected Tropical Diseases (2017)

Review Parasitology

Biology and pathogenesis of Naegleria fowleri

Ruqaiyyah Siddiqui et al.

ACTA TROPICA (2016)

Review Biotechnology & Applied Microbiology

The unique chemistry and biology of the piericidins

Xuefeng Zhou et al.

JOURNAL OF ANTIBIOTICS (2016)

Review Microbiology

Naegleria fowleri after 50 years: is it a neglected pathogen?

Moises Martinez-Castillo et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2016)

Review Plant Sciences

Natural Products as Sources of New Drugs from 1981 to 2014

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2016)

Review Biochemistry & Molecular Biology

The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery

Paul R. Jensen et al.

NATURAL PRODUCT REPORTS (2015)

Article Infectious Diseases

Diagnosis, Clinical Course, and Treatment of Primary Amoebic Meningoencephalitis in the United States, 1937-2013

Linda G. Capewell et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2015)

Article Biochemistry & Molecular Biology

Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain

Lyudmila N. Lysenkova et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Review Biochemistry & Molecular Biology

Natural Products as a Source for Treating Neglected Parasitic Diseases

Dieudonne Ndjonka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Biotechnology & Applied Microbiology

A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A

Lyudmila N. Lysenkova et al.

JOURNAL OF ANTIBIOTICS (2012)

Review Plant Sciences

Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2012)

Review Biochemistry & Molecular Biology

Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites

Michael Wink

MOLECULES (2012)

Review Infectious Diseases

Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment

Govinda S. Visvesvara

CURRENT OPINION IN INFECTIOUS DISEASES (2010)

Article Public, Environmental & Occupational Health

The epidemiology of primary amoebic meningoencephalitis in the USA, 1962-2008

J. S. Yoder et al.

EPIDEMIOLOGY AND INFECTION (2010)

Review Mycology

Amphotericin B: side effects and toxicity

Rafael Laniado-Laborin et al.

REVISTA IBEROAMERICANA DE MICOLOGIA (2009)

Review Immunology

The immune response to Naegleria fowleri amebae and pathogenesis of infection

Francine Marciano-Cabral et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)

Article Biochemistry & Molecular Biology

Developing a new resource for drug discovery: marine actinomycete bacteria

William Fenical et al.

NATURE CHEMICAL BIOLOGY (2006)

Article Parasitology

Natural products as antiparasitic drugs

O Kayser et al.

PARASITOLOGY RESEARCH (2003)